0001950047-23-001468.txt : 20230609 0001950047-23-001468.hdr.sgml : 20230609 20230609200757 ACCESSION NUMBER: 0001950047-23-001468 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Revance Therapeutics, Inc. CENTRAL INDEX KEY: 0001479290 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770551645 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36297 FILM NUMBER: 231006842 BUSINESS ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: 6157247755 MAIL ADDRESS: STREET 1: 1222 DEMONBREUN STREET STREET 2: SUITE 2000 CITY: NASHVILLE STATE: TN ZIP: 37203 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Foley Mark J CENTRAL INDEX KEY: 0001529196 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: ZELTIQ AESTHETICS INC. STREET 2: 4698 WILLOW ROAD SUITE 100 CITY: PLEASANTON STATE: CA ZIP: 94588 144 1 primary_doc.xml 144 0001529196 XXXXXXXX LIVE 0001479290 REVANCE THERAPEUTICS, INC. 001-36297 1222 Demonbreun Street, Suite 2000 Nashville TN 37203 (615) 724-7755 MARK FOLEY Officer Director Common E*TRADE FINANCIAL CORPORATION

3 EDISON DRIVE ALPHARETTA GA 30005

31279 960901.30 84040352 06/09/2023 NASD COMMON 10/05/2017 Open Market Purchase ISSUER N 26279 10/05/2017 Not Applicable COMMON 09/30/2020 Performance Shares ISSUER N 5000 09/30/2020 Not Applicable N MARK FOLEY

1222 Demonbreun Street, Suite 2000 Nashville TN 37203

COMMON 05/15/2023 70447 2420339.00 06/09/2023 03/10/2023 /s/ Mark Joseph Foley